Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Anemia

Free Subscription Articles published in Kidney Int Retrieve available abstracts of 27 articles: HTML format

Single Articles

November 2022
1. KETTRITZ R, Duttmann W, Brand A, Luft FC, et al
   The Case | Is this hemolytic uremic syndrome?
   Kidney Int. 2022;102:1195-1196.
   PubMed    
   
   
   August 2022
2. FUCHS MAA, Kurtz A
   The fate of erythropoietin-producing cells: another piece of the puzzle.
   Kidney Int. 2022;102:230-233.
   PubMed     Abstract available
   
   
   June 2022
3. BATTE A, Menon S, Ssenkusu JM, Kiguli S, et al
   Neutrophil gelatinase-associated lipocalin is elevated in children with acute kidney injury and sickle cell anemia, and predicts mortality.
   Kidney Int. 2022 Jun 16. pii: S0085-2538(22)00453.
   PubMed     Abstract available
   
   
   
4. VAN DEN BROEK B, van der Flier M, van de Kar NCAJ, Wetzels JFM, et al
   Eculizumab impairs killing of Neisseria meningitidis serogroup B in atypical hemolytic uremic syndrome patients vaccinated with MenB-4C.
   Kidney Int. 2022;101:1293-1295.
   PubMed    
   
   
   
5. WAGENER FADTG, van de Kar NCAJ, van den Heuvel LP
   Protective mechanisms harnessing against injurious heme and preventing kidney damage in STEC-HUS: toward new therapies?
   Kidney Int. 2022;101:1107-1109.
   PubMed     Abstract available
   
   
   
6. PIRSCHEL W, Mestekemper AN, Wissuwa B, Krieg N, et al
   Divergent roles of haptoglobin and hemopexin deficiency for disease progression of Shiga-toxin-induced hemolytic-uremic syndrome in mice.
   Kidney Int. 2022;101:1171-1185.
   PubMed     Abstract available
   
   
   May 2022
7. KANEKO K, Sato Y, Uchino E, Toriu N, et al
   Lineage tracing analysis defines erythropoietin-producing cells as a distinct subpopulation of resident fibroblasts with unique behaviors.
   Kidney Int. 2022 May 26. pii: S0085-2538(22)00376.
   PubMed     Abstract available
   
   
   
8. LABES R, Brinkmann L, Kulow VA, Roegner K, et al
   Daprodustat prevents Cyclosporine-A mediated anemia and peritubular capillary loss.
   Kidney Int. 2022 May 25. pii: S0085-2538(22)00375.
   PubMed     Abstract available
   
   
   April 2022
9. HANUDEL MR, Czaya B, Wong S, Rappaport M, et al
   Enteral ferric citrate absorption is dependent on the iron transport protein ferroportin.
   Kidney Int. 2022;101:711-719.
   PubMed     Abstract available
   
   
   
10. HAASE VH
    The ins and outs of ferric citrate.
    Kidney Int. 2022;101:668-670.
    PubMed     Abstract available
    
    
    March 2022
11. JOLES JA
    Anemia and red blood cell deformability in proteinuric chronic kidney disease.
    Kidney Int. 2022;101:649.
    PubMed    
    
    
    December 2021
12. DRUEKE TB, Massy ZA
    Role of proteinuria in the anemia of chronic kidney disease.
    Kidney Int. 2021;100:1160-1162.
    PubMed     Abstract available
    
    
    September 2021
13. BISSINGER R, Nemkov T, D Alessandro A, Grau M, et al
    Proteinuric chronic kidney disease is associated with altered red blood cell lifespan, deformability and metabolism.
    Kidney Int. 2021 Sep 16. pii: S0085-2538(21)00858.
    PubMed     Abstract available
    
    
    August 2021
14. LILL JK, Thiebes S, Pohl JM, Bottek J, et al
    Tissue-resident macrophages mediate neutrophil recruitment and kidney injury in shiga toxin-induced hemolytic uremic syndrome.
    Kidney Int. 2021;100:349-363.
    PubMed     Abstract available
    
    
    
15. BOUWMEESTER RN, van de Kar NCAJ, Wetzels JFM
    Enough is enough: targeted eculizumab withdrawal in atypical hemolytic uremic syndrome.
    Kidney Int. 2021;100:265-268.
    PubMed    
    
    
    July 2021
16. SCIESIELSKI LK, Felten M, Michalick L, Kirschner KM, et al
    The circadian clock regulates rhythmic erythropoietin expression in the murine kidney.
    Kidney Int. 2021 Jul 29. pii: S0085-2538(21)00729.
    PubMed     Abstract available
    
    
    
17. IKEDA Y
    Novel roles of HIF-PHIs in chronic kidney disease: the link between iron metabolism, kidney function, and FGF23.
    Kidney Int. 2021;100:14-16.
    PubMed     Abstract available
    
    
    
18. ARICETA G, Dixon BP, Kim SH, Kapur G, et al
    The long-acting C5 inhibitor, ravulizumab, is effective and safe in pediatric patients with atypical hemolytic uremic syndrome naive to complement inhibitor treatment.
    Kidney Int. 2021;100:225-237.
    PubMed     Abstract available
    
    
    June 2021
19. KOYUN M, Kaya Aksoy G, Comak E, Ozaltin F, et al
    Outcome of diacylglycerol kinase epsilon-mediated hemolytic uremic syndrome in an infant.
    Kidney Int. 2021;99:1500-1501.
    PubMed    
    
    
    April 2021
20. BABITT JL, Eisenga MF, Haase VH, Kshirsagar AV, et al
    Controversies in Optimal Anemia Management: Conclusions from a Kidney Disease Improving Global Outcomes (KDIGO) Conference.
    Kidney Int. 2021 Apr 8. pii: S0085-2538(21)00355.
    PubMed     Abstract available
    
    
    March 2021
21. HANUDEL MR, Wong S, Jung G, Qiao B, et al
    Amelioration of chronic kidney disease-associated anemia by vadadustat in mice is not dependent on erythroferrone.
    Kidney Int. 2021 Mar 31. pii: S0085-2538(21)00354.
    PubMed     Abstract available
    
    
    
22. FUCHS MAA, Broeker KAE, Schrankl J, Burzlaff N, et al
    Inhibition of transforming growth factor beta1 signaling in resident interstitial cells attenuates profibrotic gene expression and preserves erythropoietin production during experimental kidney fibrosis in mice.
    Kidney Int. 2021 Mar 8. pii: S0085-2538(21)00278.
    PubMed     Abstract available
    
    
    January 2021
23. VILLE S, Le Bot S, Chapelet-Debout A, Blancho G, et al
    Atypical HUS relapse triggered by COVID-19.
    Kidney Int. 2021;99:267-268.
    PubMed    
    
    
    November 2020
24. NORIS M, Remuzzi G
    Atypical hemolytic uremic syndrome associated with a factor B genetic variant and fluid-phase complement activation: an exception to the rule?
    Kidney Int. 2020;98:1084-1087.
    PubMed     Abstract available
    
    
    
25. HASSANEIN M, Liaqat A, Paratore DA, Vachharajani TJ, et al
    The Case | Arrhythmias in a patient with sickle cell disease on hemodialysis.
    Kidney Int. 2020;98:1357-1358.
    PubMed    
    
    
    May 2019
26. CAVERO T, Arjona E, Soto K, Caravaca-Fontan F, et al
    Severe and malignant hypertension are common in primary atypical hemolytic uremic syndrome.
    Kidney Int. 2019 May 31. pii: S0085-2538(19)30582.
    PubMed     Abstract available
    
    
    
27. CHO ME, Hansen JL, Peters CB, Cheung AK, et al
    An increased mortality risk is associated with abnormal iron status in diabetic and non-diabetic Veterans with predialysis chronic kidney disease.
    Kidney Int. 2019 May 15. pii: S0085-2538(19)30506.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Anemia is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: